Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Gastric Cancer

Free Subscription 06.07.2026 1 Am J Clin Oncol 1 Anticancer Res 7 BMC Cancer 7 BMC Gastroenterol 5 BMC Surg 2 Br J Cancer 1 Clin Res Hepatol Gastroenterol 1 Curr Treat Options Oncol 1 Eur J Surg Oncol 1 J Gastroenterol Hepatol 1 Oncol Rep

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Oncol

1. SCHOENEICH R, Patel RR, Lee BR, Disano P, et al
   Care Patterns and Gastric Cancer-Related Outcomes in Patients With Pathogenic/Likely Pathogenic Germline CDH1 Variants: A 14-Year Single-Center Analysis.
   Am J Clin Oncol. 2026 Jun 30. doi: 10.1097/COC.0000000000001350.
   PubMed         Abstract available
   
   

   
   Anticancer Res

2. HASHIMOTO I, Ando T, Miwa T, Araki T, et al
   Survival Benefit and Prognostic Determinants of Conversion Surgery in Patients With Stage IV Gastric Cancer: A Single-center Study.
   Anticancer Res. 2026;46:3985-3997.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. FAZHI Z, Shangzhi H, Zhi D, Yang L, et al
   Integrating spatial lymph node patterns and multimodal clinicopathological features to predict post-neoadjuvant recurrence in gastric adenocarcinoma: a machine learning nomogram.
   BMC Cancer. 2026;26:484.
   PubMed         Abstract available
   
   
4. HAN Y, Wang Q, Chen Y, Wu H, et al
   Platinum-free triplet therapy with nab-paclitaxel, S-1, and tislelizumab as first-line treatment for advanced gastric/gastroesophageal junction adenocarcinoma: a phase ii single-arm trial.
   BMC Cancer. 2026;26:546.
   PubMed         Abstract available
   
   
5. BIEGLER O, Behrens HM, Haag J, Becker T, et al
   MYC amplification is common in cancer of the stomach and gastroesophageal junction, correlates with male sex and reduced response to neoadjuvant therapy.
   BMC Cancer. 2026;26:525.
   PubMed         Abstract available
   
   
6. ZHENG Q, Xie X, Guo Q, Chen C, et al
   Prognostic value of tumor-infiltrating lymphocytes and common subtypes in patients with gastroenteropancreatic neuroendocrine neoplasms: a systematic review and meta-analysis.
   BMC Cancer. 2026;26:793.
   PubMed         Abstract available
   
   
7. YI W, Muhetaer K, Chen L, Ma X, et al
   Immunotherapy combined with chemotherapy as first-line treatment for HER2-negative advanced gastric or gastroesophageal junction cancer: systematic review and Bayesian network meta-analysis based on specific PD-L1 expression levels.
   BMC Cancer. 2026;26:780.
   PubMed         Abstract available
   
   
8. WU Y, Zhou J, Li S, Xuan Y, et al
   Perioperative NLR/PLR dynamic phenotypes and prediction of postoperative recurrence in locally advanced gastric cancer: a retrospective cohort study.
   BMC Cancer. 2026 Jun 30. doi: 10.1186/s12885-026-16431.
   PubMed         Abstract available
   
   
9. WANG X, Yu J, Sun Z, Sun Y, et al
   Integrated bioinformatic multi-omics analysis and experimental verification reveal the oncogenic role of WDHD1 and its underlying mechanism in gastric cancer progression.
   BMC Cancer. 2026 Jul 2. doi: 10.1186/s12885-026-16401.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

10. CHEN JH, Cai ZM, Yang ZR, Lin T, et al
    Comparative efficacy of neoadjuvant imatinib therapy in gastric versus rectal gastrointestinal stromal tumors: a two-center retrospective cohort study.
    BMC Gastroenterol. 2025;26:8.
    PubMed         Abstract available
    
    
11. WANG K, Liu X, Zhao J, Chen Z, et al
    PAX5 expression and its diagnostic utility in gastroenteropancreatic neuroendocrine neoplasm.
    BMC Gastroenterol. 2025;25:870.
    PubMed         Abstract available
    
    
12. NARASIMHAN V, Pulakkat Warrier S, John JJ, T MP, et al
    Predicting clinical outcomes in Helicobacter pylori-positive patients using supervised learning through the integration of demographic and genomic features.
    BMC Gastroenterol. 2026 Jan 29. doi: 10.1186/s12876-025-04595.
    PubMed        
    
    
13. SCHMITZ T, Reizner J, Sha S, Schottker B, et al
    Risk score for esophageal and gastric cancer in the over 50-year-old population based on self-reported information -the RISC-GAP project.
    BMC Gastroenterol. 2026;26:387.
    PubMed         Abstract available
    
    
14. LIM NR, Chung WC
    Microsatellite instable early gastric cancers; a distinct molecular profile with HER2 over-expression and increased multiple lesion risk.
    BMC Gastroenterol. 2026 Jun 30. doi: 10.1186/s12876-026-05053.
    PubMed         Abstract available
    
    
15. KIM JW, Yeom DH, Park SY, Seo SY, et al
    Long-term clinical outcomes of gastric mucosa-associated lymphoid tissue lymphoma: a retrospective study in regions with a high prevalence of Helicobacter pylori infection.
    BMC Gastroenterol. 2026 Mar 3. doi: 10.1186/s12876-026-04699.
    PubMed        
    
    
16. LI Y, Li M, Ren L, Zhang F, et al
    Routine magnifying endoscopy mode improved the diagnostic efficacy of opportunistic screening for early upper gastrointestinal neoplasms: a prospective, randomized controlled study.
    BMC Gastroenterol. 2026;26:239.
    PubMed         Abstract available
    
    

    
    BMC Surg

17. ZHANG Z, Liu D, Wang S, Wang B, et al
    Comparative study of the outcomes of robotic versus laparoscopic distal gastrectomy with hand-sewn anastomosis in Billroth-I reconstruction.
    BMC Surg. 2025;26:1.
    PubMed         Abstract available
    
    
18. QIAN YL, Ye K, Wu CY
    Applications on proximal gastrectomy with gastroesophageal muscular flap anastomosis in laparoscopic surgery: a narrative review.
    BMC Surg. 2026;26:222.
    PubMed         Abstract available
    
    
19. JIMENEZ HENRIQUEZ RM, Kalandarishvili M, Lummer V, Weitz J, et al
    Anastomotic leakage after esophagogastric resection increases recurrence risk and impairs long-term survival - a propensity score-matched analysis.
    BMC Surg. 2026;26:279.
    PubMed         Abstract available
    
    
20. XU W, Tian Y, Xia R, Wu Y, et al
    Clinical evaluation of right-sided overlap with single flap valvuloplasty and double tract reconstruction after proximal gastrectomy.
    BMC Surg. 2026;26:267.
    PubMed         Abstract available
    
    
21. WANG Z, Tang J, She Q, Guo Z, et al
    Dynamic inflammatory responses guide anastomotic strategy in laparoscopic gastrectomy: a prospective cohort study.
    BMC Surg. 2026;26:341.
    PubMed         Abstract available
    
    

    
    Br J Cancer

22. GORDON A, Tran A, Fong C, Cromarty S, et al
    Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial.
    Br J Cancer. 2026;135:240-247.
    PubMed         Abstract available
    
    
23. FLANDERS L, Savy T, Ficial M, Al-Ghraibawi N, et al
    PD-L1 CPS in gastroesophageal cancer: differences in routine care versus Checkmate 649 and implications for biopsy-site choice and assay standardisation.
    Br J Cancer. 2026;135:232-239.
    PubMed         Abstract available
    
    

    
    Clin Res Hepatol Gastroenterol

24. YU Z, Jiao J, Liang C, Hou S, et al
    The Disease Burden of Gastric Cancer in China, 1990-2023: A Comprehensive Analysis and Projections to 2035.
    Clin Res Hepatol Gastroenterol. 2026 Jul 2:102882.
    PubMed         Abstract available
    
    

    
    Curr Treat Options Oncol

25. MOHINDROO C, Ramirez RA
    Management of Peptide Receptor Radionuclide Therapy Toxicities in Neuroendocrine Neoplasm Patients.
    Curr Treat Options Oncol. 2026;27:6.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

26. LU X, Cui X, Chen H, Zhang J, et al
    Association of body composition parameters with pathological response to neoadjuvant immunochemotherapy in locally advanced gastric cancer.
    Eur J Surg Oncol. 2026;52:111973.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

27. WATANABE K, Fukuda S, Kubota D, Yamamichi N, et al
    Five-Year Unified Risk Prediction Model for Gastric and Esophageal Cancer Based on Nationwide Health Check-Up Data in Japan: J-GESS Score.
    J Gastroenterol Hepatol. 2026;41:2073-2081.
    PubMed         Abstract available
    
    

    
    Oncol Rep

28. CAI X, He Y, Kang L, Zhou D, et al
    Identification of RRM2 as a key regulator of malignant epithelial cells in gastric cancer through single?cell transcriptomics.
    Oncol Rep. 2026;56:154.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum